Thiamine Deficiency
16
0
0
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
31%
5 trials in Phase 3/4
29%
4 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (16)
The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease
Prevalence of Thiamine Deficiency in Hospitalized Non-Alcoholic Veterans
Further Development and Assessment of Tools to Measure Risk Factors for and Treatment of Thiamine Deficiency Disorders
The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
Thiamine as a Renal Protective Agent in Septic Shock
Effect of Thiamine on Serum Glucagon And Reactive Oxygen Species (ROS)
The Thiamine Administration After Cardiac Surgery Trial
Thiamine Responsive Disorders (TRD) Among Infants in Lao PDR
High Dose Intravenous Thiamine for the Prevention of Delirium in Allogeneic Hematopoietic Stem Cell Transplantation
Thiamine Supplementation in Heart Failure: a Pilot Randomized Controlled Crossover Trial
Preoperative Parenteral Thiamine Supplementation in Patients Undergoing Heart Surgery
Trial of Thiamine Supplementation in Cambodia
Thiamine Influenced on Substrate Energy Effectiveness in Indonesian Children Undergoing Cardiopulmonary Bypass
Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)
Thiamine Supplementation in Patients With Septic Shock
Thiamin Deficiency in Obese Thai Children